BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 29572120)

  • 21. The prognostic significance of growth factors and growth factor receptors in gastric adenocarcinoma.
    Kim JY; Jeon TJ; Bae BN; Kwon JE; Kim HJ; Park K; Shin E
    APMIS; 2013 Feb; 121(2):95-104. PubMed ID: 23030255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy.
    Nordby Y; Andersen S; Richardsen E; Ness N; Al-Saad S; Melbø-Jørgensen C; Patel HR; Dønnem T; Busund LT; Bremnes RM
    Prostate; 2015 Nov; 75(15):1682-93. PubMed ID: 26268996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The expression of VEGF-C, VEGFR-3 and its predictive value on lymph node metastasis and prognosis of gastric cancer].
    Han FH; Zhan WH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
    Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1058-61. PubMed ID: 17074247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VEGFR-2 as a novel predictor of survival in gastric cancer: A systematic review and meta-analysis
.
    Li T; Yu J; Luo X; Ren W; Zhang Y; Cao B
    Pathol Res Pract; 2018 Apr; 214(4):560-564. PubMed ID: 29572120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic and clinical significance of VEGFR-3 in gastric cancer: A meta-analysis.
    Ge H; Yan Y; Guo L; He X; Yang X
    Clin Chim Acta; 2017 Nov; 474():114-119. PubMed ID: 28939099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysis.
    Long B; Yu Z; Zhou H; Ma Z; Ren Y; Zhan H; Li L; Cao H; Jiao Z
    Int J Surg; 2018 Aug; 56():242-249. PubMed ID: 29940258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
    Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
    Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis.
    Yiming L; Yunshan G; Bo M; Yu Z; Tao W; Gengfang L; Dexian F; Shiqian C; Jianli J; Juan T; Zhinan C
    Oncotarget; 2015 Dec; 6(39):42019-27. PubMed ID: 26503471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
    Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
    World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
    Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G
    PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic role of Leucine-rich repeat-containing G-protein-coupled receptor 5 in gastric cancer: A systematic review with meta-analysis.
    Huang T; Qiu X; Xiao J; Wang Q; Wang Y; Zhang Y; Bai D
    Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):246-53. PubMed ID: 26387842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of pSTAT3 in gastric cancer: a meta-analysis.
    Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):649-57. PubMed ID: 26233579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bcl-2 expression and patient survival in gastric cancer: a systematic review of the literature with meta-analysis.
    Cheng H; Wang X; Li T; Chen L
    Med Oncol; 2015 Jan; 32(1):389. PubMed ID: 25428392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic impact of occult lymph node metastasis in node-negative gastric cancer: a systematic review and meta-analysis.
    Huang JY; Xu YY; Li M; Sun Z; Zhu Z; Song YX; Miao ZF; Wu JH; Xu HM
    Ann Surg Oncol; 2013 Nov; 20(12):3927-34. PubMed ID: 23892524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological and prognostic value of S100A4 expression in gastric cancer: a meta-analysis.
    Ling Z; Li R
    Int J Biol Markers; 2014 Jun; 29(2):e99-e111. PubMed ID: 24242292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis.
    Liu JL; Gao W; Kang QM; Zhang XJ; Yang SG
    PLoS One; 2013; 8(8):e71930. PubMed ID: 23936532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships between abnormal MMP2 expression and prognosis in gastric cancer: a meta-analysis of cohort studies.
    Wang HL; Zhou PY; Zhang Y; Liu P
    Cancer Biother Radiopharm; 2014 May; 29(4):166-72. PubMed ID: 24784911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of the red cell distribution width in esophageal cancer patients: A systematic review and meta-analysis.
    Xu WY; Yang XB; Wang WQ; Bai Y; Long JY; Lin JZ; Xiong JP; Zheng YC; He XD; Zhao HT; Sang XT
    World J Gastroenterol; 2018 May; 24(19):2120-2129. PubMed ID: 29785080
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.